| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |